Finite element modelling of composite structures under crushing load

This paper details the theory and implementation of a composite damage model, addressing damage within a ply (intralaminar) and delamination (interlaminar), for the simulation of crushing of laminated composite structures. It includes a more accurate determination of the characteristic length to achieve mesh objectivity in capturing intralaminar damage consisting of matrix cracking and fibre failure, a load-history dependent material response, an isotropic hardening nonlinear matrix response, as well as a more physically-based interactive matrix-dominated damage mechanism. The developed damage model requires a set of material parameters obtained from a combination of standard and non-standard material characterisation tests. The fidelity of the model mitigates the need to manipulate, or "calibrate", the input data to achieve good agreement with experimental results. The intralaminar damage model was implemented as a VUMAT subroutine, and used in conjunction with an existing interlaminar damage model, in Abaqus/Explicit. This approach was validated through the simulation of the crushing of a cross-ply composite tube with a tulip-shaped trigger, loaded in uniaxial compression. Despite the complexity of the chosen geometry, excellent correlation was achieved with experimental results.

Finite element modeling of debonding failures in FRP-strengthened RC beams: A dynamic approach

This paper is concerned with the finite element simulation of debonding failures in FRP-strengthened concrete beams. A key challenge for such simulations is that common solution techniques such as the Newton-Raphson method and the arc-length method often fail to converge. This paper examines the effectiveness of using a dynamic analysis approach in such FE simulations, in which debonding failure is treated as a dynamic problem and solved using an appropriate time integration method. Numerical results are presented to show that an appropriate dynamic approach effectively overcomes the convergence problem and provides accurate predictions of test results.

Compressive behavior of steel fiber reinforced recycled aggregate concrete after exposure to elevated temperatures

For sustainability considerations, the use of recycled aggregate in concrete has attracted many interests in the research community. One of the main concerns for using such concrete in buildings is its spalling in fire. This may be alleviated by adding steel fibers to form steel fiber reinforced recycled aggregate concrete (SFRAC). This paper presents an experimental investigation into the compressive properties of SFRAC cylinders after exposure to elevated temperatures, including the compressive strength, Young's modulus (stiffness), stress-strain curve and energy absorption capacity (toughness). The effects of two parameters, namely steel fiber volume content (0%, 0.5%, 1%, 1.5%) and temperature (room temperature, 200 °C, 400 °C and 600 °C) on the compressive mechanical properties of concrete were investigated. The test results show that both compressive strength and stiffness of the concrete are significantly reduced after exposure to high temperatures. The addition of steel fibers is helpful in preventing spalling, and significantly improves the ductility and the cracking behavior of recycled aggregate concrete (RAC) after exposure to high temperatures, which is favorable for the application of RAC in building construction.

A bond model for DEM simulation of cementitious materials and deformable structures

There is an increasing use of the discrete element method (DEM) to study cemented (e.g. concrete and rocks) and sintered particulate materials. The chief advantage of the DEM over continuum based techniques is that it does not make assumptions about how cracking and fragmentation initiate and propagate, since the DEM system is naturally discontinuous. The ability for the DEM to produce a realistic representation of a cemented granular material depends largely on the implementation of an inter-particle bonded contact model. This paper presents a new bonded contact model based on the Timoshenko beam theory which considers axial, shear and bending behaviour of the bond. The bond model was first verified by simulating both the bending and dynamic response of a simply supported beam. The loading response of a concrete cylinder was then investigated and compared with the Eurocode equation prediction. The results show significant potential for the new model to produce satisfactory predictions for cementitious materials. A unique feature of this model is that it can also be used to accurately represent many deformable structures such as frames and shells, so that both particles and structures or deformable boundaries can be described in the same DEM framework. 

Experimental study on PC hollow-core slab strengthened with bamboo plates

An experimental study on strengthening prestressed concrete (PC) hollow-core slabs was conducted. Nine PC hollow-core slabs were tested, including three unstrengthened reference slabs and six slabs strengthened with bamboo plates. The results show that compared with unreinforced slabs, the cracking loads of PC hollow-core slabs strengthened with bamboo plates increase by 5% to 96% (with an average of 41%), the loads at allowable deflection increase by 8% to 76% (with an average of 35%), and the ultimate loads increase by 83% to 184% (with an average of 123%), respectively. All the degrees of improvement in the crack load, allowable load and ultimate load increase with the increase in the thickness and width of the bamboo plates. With the increase in the loads, the strain distribution along the height of the strengthened slabs at the mid-span basically remains a plan-assumption. With the increase in the thickness and width of the bamboo plates, both the bamboo tensile strain on the tensile face and the concrete compressive strain on the compression face of the strengthened slabs decrease under the same load level.

Simulating reinforced concrete members. Part 1: partial interaction properties

Reinforced concrete members are extremely complex under loading because of localised deformations in the concrete (cracks, sliding planes) and between the reinforcement and concrete (slip). An ideal model for simulating behaviour of reinforced concrete members should incorporate both global behaviour and the localised behaviours that are seen and measured in practice; these localised behaviours directly affect the global behaviour. Most commonly used models do not directly simulate these localised behaviours that can be seen or measured in real members; instead, they overcome these limitations by using empirically or semi-empirically derived strain-based pseudo properties such as the use of effective flexural rigidities for deflection; plastic hinge lengths for strength and ductility; and energy-based approaches for both concrete softening in compression and concrete softening after tensile cracking to allow for tension stiffening. Most reinforced concrete member experimental testing is associated with deriving these pseudo properties for use in design and analysis, and this component of development is thus costly. The aim of the present research is to reduce this cost substantially. In this paper, localised material behaviours and the mechanisms they induce are described. Their incorporation into reinforced concrete member behaviour without the need for empirically derived pseudo properties is described in a companion paper.

Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl

Expression of the transforming oncogene bcr-abl in chronic myelogenous leukemia (CML) cells is reported to confer resistance against apoptosis induced by many chemotherapeutic agents such as etoposide, ara-C, and staurosporine. In the present study some members of a series of novel pyrrolo-1,5-benzoxazepines potently induce apoptosis, as shown by cell shrinkage, chromatin condensation, DNA fragmentation, and poly(ADP-ribose) polymerase (PARP) cleavage, in three CML cell lines, K562, KYO.1, and LAMA 84. Induction of apoptosis by a representative member of this series, PBOX-6, was not accompanied by either the down-regulation of Bcr-Abl or by the attenuation of its protein tyrosine kinase activity up to 24 h after treatment, when approximately 50% of the cells had undergone apoptosis. These results suggest that down-regulation of Bcr-Abl is not part of the upstream apoptotic death program activated by PBOX-6. By characterizing the mechanism in which this novel agent executes apoptosis, this study has revealed that PBOX-6 caused activation of caspase 3-like proteases in only two of the three CML cell lines. In addition, inhibition of caspase 3-like protease activity using the inhibitor z-DEVD-fmk blocked caspase 3-like protease activity but did not prevent the induction of apoptosis, suggesting that caspase 3-like proteases are not essential in the mechanism by which PBOX-6 induces apoptosis in CML cells. In conclusion, this study demonstrates that PBOX-6 can bypass Bcr-Abl-mediated suppression of apoptosis, suggesting an important potential use of these compounds in the treatment of CML.

Selecting the best targeted agent in first-line treatment of unresectable liver metastases from colorectal cancer:does the bench have the answers?

For physicians facing patients with organ-limited metastases from colorectal cancer, tumor shrinkage and sterilization of micrometastatic disease is the main goal, giving the opportunity for secondary surgical resection. At the same time, for the majority of patients who will not achieve a sufficient tumor response, disease control remains the predominant objective. Since FOLFOX or FOLFIRI have similar efficacies, the challenge is to define which could be the most effective targeted agent (anti-EGFR or anti-VEGF) to reach these goals. Therefore, a priori molecular identification of patients that could benefit from anti-EGFR or anti-VEGF monoclonal antibodies (i.e. the currently approved targeted therapies for metastatic colorectal cancer) is of critical importance. In this setting, the KRAS mutation status was the first identified predictive marker of response to anti-EGFR therapy. Since it has been demonstrated that tumors with KRAS mutation do not respond to anti-EGFR therapy, KRAS status must be determined prior to treatment. Thus, for KRAS wild-type patients, the choices that remain are either anti-VEGF or anti-EGFR. In this review, we present the most updated data from translational research programs dealing with the identification of biomarkers for response to targeted therapies.